Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe page now includes a government funding status notice and a new revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoChange DetectedThe changes are minor UI and wording updates (Show glossary, capitalization tweaks in QC-related labels, and revision/version indicators) that do not modify study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3 entry.SummaryDifference0.0%

- Check45 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure text and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check74 days agoChange DetectedPublications section wording updated to clarify that publications are automatically filled from PubMed and may not be about the study, and the revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check81 days agoChange DetectedThe government funding status notice on the page has been removed.SummaryDifference0.3%

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.